KITE PHARMA
Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.
KITE PHARMA
Industry:
Biotechnology Health Care Medical
Founded:
2009-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.kitepharma.com
Total Employee:
51+
Status:
Active
Contact:
(310) 824-9999
Email Addresses:
[email protected]
Total Funding:
335.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Euro IPv6 JsDelivr
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Arie Belldegrun
Arie Belldegrun investment in Debt Financing - Kite Pharma
Two River
Two River investment in Series A - Kite Pharma
Alta Partners
Alta Partners investment in Series A - Kite Pharma
Two River
Two River investment in Series A - Kite Pharma
Riverbank Capital Securities
Riverbank Capital Securities investment in Series A - Kite Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | Kite Pharma investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2021-11-02 | Shoreline Biosciences | Kite Pharma investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-02-24 | Orna Therapeutics | Kite Pharma investment in Series A - Orna Therapeutics | 80 M USD |
| 2021-02-07 | Shoreline Biosciences | Kite Pharma investment in Series A - Shoreline Biosciences | 43 M USD |
| 2020-07-09 | Fosun Kite Biotechnology | Kite Pharma investment in Corporate Round - Fosun Kite Biotechnology | 20 M USD |
| 2020-02-05 | Vineti | Kite Pharma investment in Series C - Vineti | 35 M USD |
| 2019-08-28 | HiFiBiO | Kite Pharma investment in Series C - HiFiBiO | 67 M USD |
| 2018-07-20 | Gadeta | Kite Pharma investment in Funding Round - Gadeta | N/A |
| 2016-06-02 | Cell Design Labs | Kite Pharma investment in Venture Round - Cell Design Labs | 34.4 M USD |
Official Site Inspections
http://www.kitepharma.com Semrush global rank: 1.34 M Semrush visits lastest month: 21.75 K
- Host name: 40.70.27.35
- IP address: 40.70.27.35
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
More informations about "Kite Pharma"
Kite Pharma - Wikipedia
The company was founded in 2009 by Arie Belldegrun, an Israeli-American oncologist, who served as the company's chairman, president and chief executive officer. Belldegrun had a co-founder in Joshua Kazam, who took on the role of Director. On August 28, 2017, Gilead Sciences announced that it would acquire Kite Pharma for $11.9 billion in an all-cash deal, a 29% premium on the share price. Gilead made the purchase in larg…See details»
Our Focus on Cell Therapy | Kite Pharma
Our Story A Singular Focus on Cell Therapy. Founded in 2009 as a pioneer in cell therapy research, Kite’s leadership position in the immuno-oncology space was solidified with our research and development agreement with the National …See details»
Kite Pharma - LinkedIn
Kite Pharma | 152,475 followers on LinkedIn. At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. | At Kite, a Gilead Company, our singular focus is achieving ...See details»
Kite Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (310) 824-9999 Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to …See details»
Our Leadership - Kite Pharma
Meet the Kite leadership team and learn more about their roles within expanding cell therapy research.See details»
Gilead Sciences Completes Acquisition of Kite Pharma Inc
Oct 3, 2017 For more information on Kite, please visit www.kitepharma.com. About Gilead Sciences. Gilead Sciences is a biopharmaceutical company that discovers, develops and …See details»
Kite Pharma - LinkedIn
Kite Pharma | 152,544 followers on LinkedIn. At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. | At Kite, a Gilead Company, our singular focus is achieving …See details»
Kite Pharma Mission, Benefits, and Work Culture | Indeed.com
Sep 12, 2024 Come see what’s going on inside Kite Pharma, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make …See details»
Transformational Cancer Treatment - Kite Pharma
Our mission Transformational Cancer Treatment. At Kite, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as …See details»
Kite Pharma Company Profile - Craft
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy. It provides Yescarta and Tecartus, which are chimeric antigen receptor T (CAR T) cell therapies …See details»
Kite Pharma CEO and Key Executive Team | Craft.co
Kite Pharma's Executive Vice President is Cindy Perettie. Other executives include Warner Biddle, Senior Vice President and Global Head of Commercial; Priti Hegde, Senior Vice …See details»
Kite Pharma - YouTube
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. Visit kitepharma.com to learn more. See our community guidelines: https://bit.ly/2DznMNwSee details»
Kite Pharma - LinkedIn
Kite Pharma | 152.544 volgers op LinkedIn. At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. | At Kite, a Gilead Company, our singular focus is achieving …See details»
Execs from Bayer, Kite and Orca sound off on their launch …
May 20, 2024 Internal alignment across the organization during clinical development and nimbleness in the growth stage should be top priorities, according to executives from Bayer, …See details»
Kite Pharma - Overview, News & Similar companies - ZoomInfo
Aug 30, 2024 www.kitepharma.com. Revenue $353.2 Million. Industry Pharmaceuticals Healthcare . Most Recent Scoops. Sep 10 2024. Open Position ... the first Integrated …See details»
Contact Information - Kite Pharma
Kite Corporate Headquarters 2400 Broadway Santa Monica, CA 90404 (310) 824-9999 (310) 824-9999 Email: [email protected] For Kite medical information, clinical trial …See details»
Our Locations - Kite Pharma
Kite locations. Kite has locations around the globe, including our corporate headquarters in Santa Monica, California, our cell therapy manufacturing facilities in El Segundo, California and …See details»
Kite Pharma: Where Global Health and Sustainability Align
Mar 1, 2024 Sustainability Magazine connects the leading sustainability and ESG executives of the world's largest brands. Our platform serves as a digital hub for connecting industry …See details»
Careers at Kite - Kite Pharma
As an equal opportunity employer, Gilead Sciences, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination …See details»